Laurence Morand-Joubert Selected Research

efavirenz (Sustiva)

7/2015	HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007-12: impact on susceptibility to first-line strategies.
1/2011	Higher efficacy of nevirapine than efavirenz to achieve HIV-1 plasma viral load below 1 copy/ml.
7/2009	A randomized trial of two-drug versus three-drug tenofovir-containing maintenance regimens in virologically controlled HIV-1 patients.
3/2009	Influence of liver fibrosis stage on plasma levels of efavirenz in HIV-infected patients with chronic hepatitis B or C.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laurence Morand-Joubert Research Topics

Disease

4	Infections 01/2022 - 07/2015
3	COVID-19 01/2022 - 10/2020
3	Acquired Immunodeficiency Syndrome (AIDS) 01/2018 - 05/2008
3	Hepatitis 01/2018 - 03/2009
2	Encephalitis (Encephalitis, Rasmussen) 01/2017 - 09/2010
2	Viremia 01/2014 - 01/2011
2	Coinfection 01/2014 - 03/2009
1	Critical Illness (Critically Ill) 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 10/2021
1	HIV Infections (HIV Infection) 01/2018
1	Meningoencephalitis 03/2009
1	Chronic Hepatitis B 03/2009
1	Chronic Hepatitis (Chronic Active Hepatitis) 03/2009
1	Liver Cirrhosis (Hepatic Cirrhosis) 03/2009
1	Fibrosis (Cirrhosis) 03/2009

Drug/Important Bio-Agent (IBA)

4	RNA (Ribonucleic Acid)IBA 11/2018 - 05/2008
4	efavirenz (Sustiva)FDA Link 07/2015 - 03/2009
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2009
2	Pharmaceutical PreparationsIBA 01/2018 - 07/2009
2	Tenofovir (Viread)FDA Link 01/2011 - 07/2009
1	IntegrasesIBA 01/2022
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2022
1	NucleosidesIBA 01/2022
1	Reverse Transcriptase InhibitorsIBA 01/2022
1	BNT162 VaccineIBA 10/2021
1	COVID-19 VaccinesIBA 10/2021
1	VaccinesIBA 10/2021
1	Immunoglobulin G (IgG)IBA 10/2020
1	AntibodiesIBA 10/2020
1	Rilpivirine (TMC-278)IBA 01/2018
1	Viral RNAIBA 01/2017
1	Interleukin-10 (Interleukin 10)IBA 01/2014
1	Nevirapine (Viramune)FDA Link 01/2011
1	Emtricitabine (Emtriva)FDA Link 01/2011
1	Lamivudine (Epivir)FDA Link 07/2009
1	etravirine (TMC-125)FDA Link 03/2009
1	Lopinavir FDA Link 05/2008
1	amprenavir (Agenerase)FDA Link 05/2008

Therapy/Procedure

3	Therapeutics 01/2017 - 03/2009